• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经丝氨酸蛋白酶(KLK6)是一种与衰老相关的蛋白酶,其脑脊液水平降低可能是阿尔茨海默病的一种新的风险因素。

Decreased cerebrospinal fluid levels of neurosin (KLK6), an aging-related protease, as a possible new risk factor for Alzheimer's disease.

作者信息

Mitsui Shinichi, Okui Akira, Uemura Hidetoshi, Mizuno Toshiki, Yamada Tatsuo, Yamamura Yoshio, Yamaguchi Nozomi

机构信息

Department of Cell Biology, Research Institute for Geriatrics, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kyoto 602-8566, Japan.

出版信息

Ann N Y Acad Sci. 2002 Nov;977:216-23. doi: 10.1111/j.1749-6632.2002.tb04818.x.

DOI:10.1111/j.1749-6632.2002.tb04818.x
PMID:12480753
Abstract

Neurosin is a kallikrein-like serine protease expressed preferentially in the human brain. It is localized in senile plaques and neurofibrillary tangles in the brains of individuals with Alzheimer's disease (AD) and in Lewy bodies in patients with Parkinson's disease. Neurosin is present in the cerebrospinal fluid (CSF) as a proenzyme and does not show any enzymatic activity. We have developed a sandwich ELISA system using monoclonal and polyclonal antibodies against human neurosin and have measured neurosin levels in the CSF from AD and non-CNS disease patients. Both male and female patients with peripheral neuropathy showed statistically positive correlations between CSF neurosin concentrations and age (males, n = 52, r = 0.482, p < 0.005; females, n = 43, r = 0.365, p < 0.005). In contrast, such positive correlation was not observed in the CSF from patients with AD. Further, some such patients showed extremely low levels of CSF neurosin. Our results suggest that neurosin is an aging-related protease and that a decreased CSF concentration of neurosin may be a risk factor for developing AD.

摘要

神经丝氨酸蛋白酶是一种类激肽释放酶的丝氨酸蛋白酶,在人类大脑中优先表达。它定位于阿尔茨海默病(AD)患者大脑中的老年斑和神经原纤维缠结以及帕金森病患者的路易小体中。神经丝氨酸蛋白酶以酶原形式存在于脑脊液(CSF)中,不显示任何酶活性。我们利用抗人神经丝氨酸蛋白酶的单克隆抗体和多克隆抗体开发了一种夹心酶联免疫吸附测定(ELISA)系统,并测定了AD患者和非中枢神经系统疾病患者脑脊液中的神经丝氨酸蛋白酶水平。患有周围神经病变的男性和女性患者脑脊液中神经丝氨酸蛋白酶浓度与年龄之间均存在统计学上的正相关(男性,n = 52,r = 0.482,p < 0.005;女性,n = 43,r = 0.365,p < 0.005)。相比之下,在AD患者的脑脊液中未观察到这种正相关。此外,一些此类患者脑脊液中的神经丝氨酸蛋白酶水平极低。我们的结果表明,神经丝氨酸蛋白酶是一种与衰老相关的蛋白酶,脑脊液中神经丝氨酸蛋白酶浓度降低可能是发生AD的一个危险因素。

相似文献

1
Decreased cerebrospinal fluid levels of neurosin (KLK6), an aging-related protease, as a possible new risk factor for Alzheimer's disease.神经丝氨酸蛋白酶(KLK6)是一种与衰老相关的蛋白酶,其脑脊液水平降低可能是阿尔茨海默病的一种新的风险因素。
Ann N Y Acad Sci. 2002 Nov;977:216-23. doi: 10.1111/j.1749-6632.2002.tb04818.x.
2
Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy.在突触核蛋白病患者的脑脊液中,α-突触核蛋白和α-突触核蛋白裂解酶神经酶的水平均较低。
PLoS One. 2013;8(1):e53250. doi: 10.1371/journal.pone.0053250. Epub 2013 Jan 8.
3
Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease.一种新型类胰蛋白酶丝氨酸蛋白酶——神经丝氨酸蛋白酶在阿尔茨海默病和帕金森病脑组织中的定位
Psychiatry Clin Neurosci. 2000 Aug;54(4):419-26. doi: 10.1046/j.1440-1819.2000.00731.x.
4
Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease.评估激肽释放酶 6 作为阿尔茨海默病的横断面和纵向生物标志物。
Alzheimers Res Ther. 2018 Jan 29;10(1):9. doi: 10.1186/s13195-018-0336-4.
5
Characterization of a brain-related serine protease, neurosin (human kaillikrein 6), in human cerebrospinal fluid.人脑脊液中一种与脑相关的丝氨酸蛋白酶——神经丝氨酸蛋白酶(人组织激肽释放酶6)的特性研究
Neuroreport. 2001 May 25;12(7):1345-50. doi: 10.1097/00001756-200105250-00011.
6
Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.阿尔茨海默病和额颞叶痴呆患者脑脊液中激肽释放酶7和10浓度的改变。
Clin Biochem. 2004 Mar;37(3):230-7. doi: 10.1016/j.clinbiochem.2003.11.012.
7
Value of measuring plasmatic levels of neurosin in the diagnosis of Alzheimer's disease.测量神经丝氨酸血浆水平在阿尔茨海默病诊断中的价值。
J Alzheimers Dis. 2008 May;14(1):59-67. doi: 10.3233/jad-2008-14106.
8
Low levels of soluble NG2 in cerebrospinal fluid from patients with dementia with Lewy bodies.路易体痴呆患者脑脊液中可溶性NG2水平较低。
J Alzheimers Dis. 2014;40(2):343-50. doi: 10.3233/JAD-132246.
9
Extracellular neurosin degrades α-synuclein in cultured cells.细胞外神经丝氨酸蛋白酶降解培养细胞中的α-突触核蛋白。
Neurosci Res. 2010 Aug;67(4):341-6. doi: 10.1016/j.neures.2010.04.008. Epub 2010 Apr 18.
10
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.轻度认知障碍与阿尔茨海默病病理及脑梗死有关。
Neurology. 2005 Mar 8;64(5):834-41. doi: 10.1212/01.WNL.0000152982.47274.9E.

引用本文的文献

1
Multiplex Proteomics of Lewy Body Dementia Reveals Cerebrospinal Fluid Biomarkers of Disease Pathology and Progression.路易体痴呆的多重蛋白质组学揭示了疾病病理和进展的脑脊液生物标志物。
bioRxiv. 2025 Jun 13:2025.06.10.658994. doi: 10.1101/2025.06.10.658994.
2
A Novel Mutation of the KLK6 Gene in a Family With Knee Osteoarthritis.一个患膝骨关节炎家族中KLK6基因的新型突变
Front Genet. 2021 Nov 11;12:784176. doi: 10.3389/fgene.2021.784176. eCollection 2021.
3
Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PET.
激肽释放酶相关肽酶6和10在阿尔茨海默病患者的脑脊液中升高,并与脑脊液总tau蛋白和氟代脱氧葡萄糖正电子发射断层扫描相关。
Transl Neurodegener. 2019 Aug 27;8:25. doi: 10.1186/s40035-019-0168-6. eCollection 2019.
4
Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease.评估激肽释放酶 6 作为阿尔茨海默病的横断面和纵向生物标志物。
Alzheimers Res Ther. 2018 Jan 29;10(1):9. doi: 10.1186/s13195-018-0336-4.
5
Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas.通过液相色谱-串联质谱分析和挖掘人类蛋白质图谱来鉴定脑脊液蛋白质组中脑富集蛋白。
Clin Proteomics. 2016 May 15;13:11. doi: 10.1186/s12014-016-9111-3. eCollection 2016.
6
Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes.激肽释放酶相关肽酶在正常和病理过程中的作用。
Dis Markers. 2015;2015:946572. doi: 10.1155/2015/946572. Epub 2015 Dec 9.
7
Correlation between KLK6 expression and the clinicopathological features of glioma.KLK6表达与胶质瘤临床病理特征的相关性
Contemp Oncol (Pozn). 2014;18(4):246-51. doi: 10.5114/wo.2014.44628. Epub 2014 Aug 30.
8
Kallikrein cascades in traumatic spinal cord injury: in vitro evidence for roles in axonopathy and neuron degeneration.创伤性脊髓损伤中的 kallikrein 级联反应:轴突病和神经元变性中作用的体外证据。
J Neuropathol Exp Neurol. 2013 Nov;72(11):1072-89. doi: 10.1097/NEN.0000000000000007.
9
Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity.激肽释放酶 6 通过蛋白酶激活受体 1 和蛋白酶激活受体 2 发出信号,促进神经元损伤,并加剧谷氨酸神经毒性。
J Neurochem. 2013 Oct;127(2):283-98. doi: 10.1111/jnc.12293. Epub 2013 May 27.
10
Low CSF levels of both α-synuclein and the α-synuclein cleaving enzyme neurosin in patients with synucleinopathy.在突触核蛋白病患者的脑脊液中,α-突触核蛋白和α-突触核蛋白裂解酶神经酶的水平均较低。
PLoS One. 2013;8(1):e53250. doi: 10.1371/journal.pone.0053250. Epub 2013 Jan 8.